(Q37781428)

23 August 2017

title

Cancer nanotechnology: application of nanotechnology in cancer therapy (English)

1 reference

23 August 2017

0 references

3

Sanjeeb K. Sahoo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20727417

20 June 2024

author name string

Ranjita Misra

1

1 reference

23 August 2017

Sarbari Acharya

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20727417

20 June 2024

publication date

18 August 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S1359644610002667?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

https://api.elsevier.com/content/article/PII:S1359644610002667?httpAccept=text/plain

20 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

20 June 2024

1 reference

23 August 2017

volume

15

1 reference

23 August 2017

issue

19-20

1 reference

23 August 2017

page(s)

842-850

1 reference

Development trends for new cancer therapeutics and vaccines.

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Immunosuppressive networks in the tumour environment and their therapeutic relevance

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanotechnology applications in surgical oncology

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Ligand-based targeted therapy for cancer tissue

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Polymeric nanoparticles for cancer therapy

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Application of nanotechnology in cancer therapy and imaging

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Biodegradable nanoparticles for cytosolic delivery of therapeutics

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Cancer nanotechnology: opportunities and challenges

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Development of liposomal anthracyclines: from basics to clinical applications

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanotech approaches to drug delivery and imaging

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Antibody-modified liposomes for cancer chemotherapy

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

On the formulation of pH-sensitive liposomes with long circulation times.

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism.

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy

20 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Targeting anti-HIV drugs to the CNS.

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation

20 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Polymer conjugates: nanosized medicines for treating cancer

20 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nano-oncology: drug delivery, imaging, and sensing

20 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanocarriers: promising vehicle for bioactive drugs

20 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

20 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery

20 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.

20 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Development of the polymer micelle carrier system for doxorubicin

20 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs

20 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy

20 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications

20 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Dendrimers in biomedical applications--reflections on the field

20 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Dendrimers in oncology: an expanding horizon

20 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Supramolecular chemistry: fluorine makes a difference

20 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting

20 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Dendrimer-based macromolecular MRI contrast agents: characteristics and application

20 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging

20 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques

20 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Bioassay of prostate-specific antigen (PSA) using microcantilevers.

20 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanotechnology applications in cancer

20 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanotechnology for cancer diagnostics: promises and challenges

20 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Structure-assigned optical spectra of single-walled carbon nanotubes

20 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Biomedical applications of functionalised carbon nanotubes

20 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanoparticles for biomedical imaging

20 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

The use of nanocrystals in biological detection

20 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

In vivo molecular and cellular imaging with quantum dots

20 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Quantum dots for live cells, in vivo imaging, and diagnostics

20 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Advances in fluorescence imaging with quantum dot bio-probes.

20 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles

20 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

20 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Therapeutic nanoparticles for drug delivery in cancer

20 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Nanoparticles in cancer therapy and diagnosis

20 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Lipid nanocapsules: a new platform for nanomedicine

20 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells

20 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Development of pH sensitive 2-(diisopropylamino)ethyl methacrylate based nanoparticles for photodynamic therapy

20 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice

20 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles

20 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Tunable plasmonic nanobubbles for cell theranostics

20 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Magnetic nanoparticles for theragnostics

20 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

Combined multimodal optical imaging and targeted gene silencing using stimuli-transforming nanotheragnostics

20 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.DRUDIS.2010.08.006

20 June 2024

Identifiers

1 reference

23 August 2017

1 reference